• article not found
  • Filters close
    Released: 25-Sep-2024 5:05 PM EDT
    Patients With Moderate-to-Severe Ulcerative Colitis May Find Significant Relief as New Treatment Option Shows Good Results in Clinical Trial
    Mount Sinai Health System

    A phase 2 trial of a monoclonal antibody known as tulisokibart for moderate-to-severe ulcerative colitis (UC) showed promising results for those who have not responded to conventional inflammatory bowel disease (IBD) treatment. The results were reported Thursday, September 26, in The New England Journal of Medicine.

    24-Sep-2024 1:35 PM EDT
    Single-Dose Gene Therapy is Potentially Life-Changing for Adults with Hemophilia B
    Perelman School of Medicine at the University of Pennsylvania

    Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion of gene therapy, according to the results of an international Phase III clinical trial published today in the New England Journal of Medicine by researchers from the University of Pennsylvania Perelman School of Medicine and a multicenter group of investigators.

    Newswise: When a Child Hurts, Validating Their Pain May Be the Best First Aid
    Released: 25-Sep-2024 4:30 PM EDT
    When a Child Hurts, Validating Their Pain May Be the Best First Aid
    University of South Australia

    In a new study from the University of South Australia, researchers say that parents and doctors should be mindful of how they talk to and treat children experiencing pain – no matter how big or small the injury – knowing that these foundational experiences can be carried forward into adulthood.

    Newswise: Unique Straining Affects Phase Transformations in Silicon, a Material Vital for Electronics
    Released: 25-Sep-2024 4:05 PM EDT
    Unique Straining Affects Phase Transformations in Silicon, a Material Vital for Electronics
    Iowa State University

    Iowa State's Valery Levitas and his collaborators have used pressure with a twisting shear to permanently deform silicon, an important material for electronics. The resulting changes in silicon's microstructure produce material phases that feature different and potentially useful properties.

    Newswise: Molecular_Designs_Lambda_Biotech_Logo.jpg
    Released: 25-Sep-2024 4:05 PM EDT
    Molecular Designs Announces Acquisition of Lamda Biotech
    Molecular Designs

    Molecular Designs, a leading provider of PCR assays, associated reagents and equipment, is excited to announce the acquisition of Lamda Biotech, a specialized provider of research products for application in molecular biology, functional genomics, proteomics and gene therapy.

    Newswise: Thermal Effects in Spintronics Systematically Assessed for First Time
    Released: 25-Sep-2024 4:05 PM EDT
    Thermal Effects in Spintronics Systematically Assessed for First Time
    University Of Illinois Grainger College Of Engineering

    A new experimental technique, reported by researchers at the University of Illinois Urbana-Champaign in the journal APL Materials, directly measures heating in spintronic devices, allowing direct comparison to other effects.

    19-Sep-2024 3:05 PM EDT
    Study Finds Certain MS Therapies May Not Slow Disability Progression
    American Academy of Neurology (AAN)

    In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not receiving treatment. The study is published in the September 25, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

    19-Sep-2024 3:05 PM EDT
    Are Gender and Sexual Identity Linked to Brain Health?
    American Academy of Neurology (AAN)

    LGBTQ+ people may be more likely to have negative brain health outcomes, including a higher risk of dementia and late-life depression, than people who are cisgender and straight, according to a study published in the September 25, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. These results do not prove that sexual or gender diversity causes neurological diseases, they only show an association.

    Released: 25-Sep-2024 3:05 PM EDT
    Climate-Smart Grazing: U. Of I. Study Shows How Weather Mitigates Nitrogen Runoff
    College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

    A new study from the University of Illinois Urbana-Champaign examines the combined influence of grazing and climate on the outflow of nitrogen from pastures into water resources under different grazing schemes.

    Released: 25-Sep-2024 3:05 PM EDT
    Retiring ITM Founder Leaves Legacy of Collaboration, Discovery, Friendship
    University of Chicago Medical Center

    Renowned physician-researcher Julian Solway, MD, goes emeritus this fall after a nearly 40-year career at the University of Chicago.

    Released: 25-Sep-2024 3:05 PM EDT
    David Meltzer named Associate Dean for Clinical Science Research, Translational
    University of Chicago Medical Center

    As an Associate Dean, Dr. Meltzer will be central in shaping the division’s strategic plans, fostering a forward-looking, multidisciplinary, and human-focused research, education, and training effort.

    Newswise: Rounds with Leadership: Boosting Your Capacity to Lead
    Released: 25-Sep-2024 3:00 PM EDT
    Rounds with Leadership: Boosting Your Capacity to Lead
    American Association of Colleges of Nursing (AACN)

    As nurse educators, we understand the importance of preparing new members of our profession to serve as expert caregivers, system innovators, and patient advocates. To thrive in these roles, nurses must develop as leaders in clinical settings, in boardrooms, and in all places where nurses impact healthcare, counsel patients, and shape policy. Building leadership capacity is essential to ensuring that nurses are contributing at the highest level and seizing every opportunity to safeguard patients, families, and the communities we serve.

    Newswise: 26-Year-Old Ph.D. Candidate Diagnosed With Rare Form of Breast Cancer - Two Separate Tumors in Different Breast Quadrants
    Released: 25-Sep-2024 2:05 PM EDT
    26-Year-Old Ph.D. Candidate Diagnosed With Rare Form of Breast Cancer - Two Separate Tumors in Different Breast Quadrants
    Sylvester Comprehensive Cancer Center

    LaShae Rolle, a Ph.D. candidate was just 26 when she was diagnosed with a rare type of breast cancer. She is now designing clinical trials and studies focused on underserved and marginalized minority communities – especially adolescents and young adults.

    Released: 25-Sep-2024 1:05 PM EDT
    Supporting Orthopedic Research Through Sport
    RUSH

    When it comes to improving health care and finding new, effective ways to treat patients, it takes a village. A village that both leads and supports research. And that’s the driving force behind the eighth annual Chicago Sports Summit. Hosted by Midwest Orthopaedics at Rush, the Summit brings together leaders from across Chicago’s dynamic sports scene.

    Newswise: How Special Is the Milky Way Galaxy?
    Released: 25-Sep-2024 1:05 PM EDT
    How Special Is the Milky Way Galaxy?
    University of Utah

    The SAGA Survey just published three new research articles that provide us with new insights into the uniqueness of our own Milky Way Galaxy after completing the census of 101 satellite systems similar to the Milky Way’s.

    Newswise: df594942-305b-4997-a8ea-ad781553b258.jpg
    Released: 25-Sep-2024 1:05 PM EDT
    New Research Shows Hydraulic Failure in the Tropics Is Expected to Increase
    Los Alamos National Laboratory

    New research shows hydraulic failure in the tropics is expected to increase

    Newswise: Argonne Physicist Honored with 2024 Science Breakthrough of the Year
    Released: 25-Sep-2024 12:05 PM EDT
    Argonne Physicist Honored with 2024 Science Breakthrough of the Year
    Argonne National Laboratory

    The German Falling Walls Foundation is recognizing Argonne physicist Saw Wai Hla for X-ray research that could be widely applied in environmental and medical research and the development of batteries and microelectronic devices.

    Newswise: UTHealth Houston’s Minimally Invasive Treatment Extends Hope to Patients with Medication-Resistant Epilepsy
    Released: 25-Sep-2024 12:05 PM EDT
    UTHealth Houston’s Minimally Invasive Treatment Extends Hope to Patients with Medication-Resistant Epilepsy
    University of Texas Health Science Center at Houston

    Findings of a study on a novel and minimally invasive laser therapy for patients with drug-resistant epilepsy caused by periventricular nodular heterotopia (PNVH) have been published by UTHealth Houston researchers in American Neurological Association’s Annals of Neurology.



    close
    0.14283